Trial | NCT00355810  Report issue

Title

Probiotics for Irritable Bowel Syndrome
Lactobacillus Plantarum MF 1298 vs Placebo for Irritable Bowel Syndrome.

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    lactobacillus plantarum ...

  • Study Participants

    19
This randomised, double blind, cross-over study compares the effect (symptoms, fecal bacterial growth, gas production) of three weeks' treatment with lactobacillus plantarum MF 1298 with placebo in patients with irritable bowel syndrome. The results are related to dietary habits, food intolerance and food allergy.
Study Started
Jan 31
2006
Primary Completion
Apr 30
2006
Study Completion
Dec 31
2006
Last Update
Jul 19
2016
Estimate

Dietary Supplement placebo followed by Lactobacillus plantarum MF 1298

placebo during 3 weeks, washout period 4 weeks, Lactobacillus plantarum MF1298 during 3 weeks

  • Other names: probiotic

Dietary Supplement Lactobacillus plantarum MF1298 followed by placebo

Lactobacillus plantarum MF1298 during 3 weeks, washout period 4 weeks, placebo during 3 weeks

  • Other names: probiotic

placebo followed by probiotic Experimental

placebo, then washout period, then Lactobacillus plantarum MF1298

probiotic followed by placebo Experimental

Lactobacillus plantarum MF1298, then washout period, then placebo

Criteria 

Inclusion Criteria:

Irritable bowel syndrome according to the Rome II criteria
regular symptoms

Exclusion Criteria:

Use of probiotics last three weeks
pregnancy
lactation
co-existing other gastrointestinal disorders
use of laxatives and antibiotics within last 5 weeks.
No Results Posted